The FDA recalles batches of myocarotic PATH-MUSCLE, SOLU. TAB

The withdrawal is due to out-of-specific laboratory results, indicated in its communication. The batches of myocarotic PATH-MUSCLE, SOLU. TAB (4+1000) MG/TAB are 2407048, 2404030, 2402019, 2402016, 2311098, 2404029, noted in the EOF announcement. The announcement states: The withdrawal of batches 2407048, 2404030, 2402019, 2402016, 2311098, 2404029 of the medicinal product PATH-MUSCLE, SOLU. TAB (4+1000) MG/TAB, due to off-specific laboratory results. This Decision shall be adopted in order to strengthen the voluntary withdrawal of the manufacturer. The company DOC PHARMA SA, as the holder of the marketing authorisation of the product in Greece, must contact its customers immediately in order to withdraw it from the market. The withdrawal documents shall be kept for a period of at least five (5) years and shall be put to the attention of the IF, if requested.